With all the required regulatory approvals in place, the Leverkusen, Germany-based company plans to close the deal on Thursday, while raising as much as 26 billion euros (US$30.41 billion) in shares and bonds. Bayer shares yesterday rose 0.6 percent to 104 euros at 10am in Frankfurt. Bayer plans to raise 6 billion euros in a rights offering and 20 billion euros from bond sales, it said on Sunday. Under the rights offering, shareholders would be able to buy two new shares for every 23 held at a price of 81 euros, Bayer said. To gain approval for the deal from the US Department of Justice, Bayer agreed to sell assets to Germany’s BASF SE.

Source: Taipei Times June 04, 2018 15:56 UTC